Lamotrigine[ Lamictal ] Drug Information

Contains Lamotrigine drug information and provides Lamotrigine drug indication, contraindication, special concerns, side effects, overdose management and dosage
Search Drugs by Generic or Trade Name:
Browse Drugs by Generic Name:
[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z ]


Indications:
Adjunct in the treatment of partial seizures in adults with epilepsy. As an adjunct in treating of generalized seizures in adults and children with Lennox-Gastaut syndrome. Conversion to monotherapy in adults with partial seizures who are receiving a single enzyme-inducing anticonvulsant drug. Investigational: Adults with generalized tonic-clonic, absence, atypical absence, myoclonic seizures, and drug-resistant seizures in epilepsy syndromes with multiple seizures types.
Back to Top
Contraindications:
Use during lactation and in children less than 16 years of age.
Back to Top
Special Concerns:
Use with caution in clients with diseases or conditions that could affect metabolism or elimination of the drug, such as in impaired renal, hepatic, or cardiac function.

Serious rashes requiring hospitilzation have been noted, especially in children. Risk of rash may be increased by giving lamotrigine with valproic acid, exceeding the recommended initial dose, and exceeding the recommended dose escalation for lamotrigine. Most rashes occur within 2-8 weeks of starting treatment but some rashes are seen after chronic treatment (e.g., 6 months).
Back to Top
Side Effects:
Side effects listed are those with an incidence of 0.1% or greater. CNS: Dizziness, ataxia, somnolence, headache, incoordination, insomnia, tremor, depression, anxiety, irritability, decreased memory, speech disorder, confusion, disturbed concentration, sleep disorder, emotional lability, vertigo, mind racing, amnesia, nervousness, abnormal thinking, abnormal dreams, agitation, akathisia, aphasia, CNS depression, depersonalization, dyskinesia, dysphoria, euphoria, faintness, hallucinations, hostility, hyperkinesia, hypesthesia, myoclonus, panic attack, paranoid reaction, personality disorder, psychosis, stupor. GI: N&V, diarrhea, dyspepsia, constipation, tooth disorder, anorexia, dry mouth, abdominal pain, dysphagia, flatulence, gingivitis, gum hyperplasia, increased appetite, increased salivation, abnormal liver function tests, mouth ulceration, stomatitis, thirst. CV: Hot flashes, palpitations, flushing, migraine, syncope, tachycardia, vasodilation. Musculoskeletal: Arthralgia, joint disorder, myasthenia, dysarthria, muscle spasm, twitching. Hematologic: Anemia, ecchymosis, leukocytosis, leukopenia, lymphadenopathy, petechiae. Hypersensitivity: Fever, lymphadenopathy, rash, multiorgan dysfunction, disseminated intravascular coagulation. Respiratory: Rhinitis, pharyngitis, increased cough, dyspnea, epistaxis, hyperventilation. Dermatologic: Stevens-Johnson syndrome, toxic epidermal necrolysis pruritus, alopecia, acne, dry skin, eczema, erythema, hirsutism, maculopapular rash, sweating, urticaria. Ophthalmologic: Diplopia, blurred vision, nystagmus, abnormal vision, abnormal accommodation, conjunctivitis, oscillopsia, photophobia. GU: Dysmenorrhea, vaginitis, amenorrhea, female lactation, hematuria, polyuria, urinary frequency or incontinence, UTI, vaginal moniliasis. Body as a whole: Possibility of sudden unexplained death in epilepsy flu syndrome, fever, infection, neck pain, malaise, seizure exacerbation, chills, halitosis, facial edema, weight gain or loss, peripheral edema, hyperglycemia. Miscellaneous: Ear pain, tinnitus, taste perversion.
Back to Top
Overdose Management:
Symptoms: Possibility of dizziness, headache, somnolence, coma. Treatment: Hospitalization with general supportive care. If indicated, induce emesis or perform gastric lavage. Protect the airway.
Back to Top
Drug Interactions:
Acetaminophen / Serum lamotrigine levels Carbamazepine / 40% in lamotrigine levels Folate inhibitors / Lamotrigine inhibits dihydrofolate reductase Phenobarbital / 40% in lamotrigine levels Phenytoin / 45%-54% in lamotrigine levels Primidone / 40% in lamotrigine levels Valproic acid / Twofold in lamotrigine levels; 25% in valproic acid levels
Back to Top
Dosage:
•Tablets Treatment of partial seizures, lamotrigine added to valproic acid.

Adults and children over 12 years of age: Weeks 1 and 2, 25 mg q other day. Weeks 3 and 4, 25 mg/day. Maintenance: To achieve maintenance doses of lamotrigine of 100-200 mg/day, increase dose by 25-50 mg/day q 1-2 weeks. Children, 2-12 years: Weeks 1 and 2 0.15 mg/kg/day in 1 or 2 divided doses, rounded down to the nearest 5 mg. If the initial dose calculated is between 2.5 and 5 mg, give 5 mg on alternate days for the first 2 weeks. Weeks 3 and 4 0.3 mg/kg/day in 1 or 2 divided doses; round down to the nearest 5 mg. Maintenance: 1-5 mg/kg/day, not to exceed 200 mg/day in 1 or 2 divided doses. To reach maintenance dose, increase dose as follows q 1-2 weeks: Calculate 0.3 mg/kg/day and round this down to the nearest 5 mg; add this amount to the previously administered daily dose.

Partial seizures, lamotrigine added to enzyme-inducing antiepileptic drugs (e.g., carbamazepine, phenobarbital, phenytoin, primidone) without valproic acid.

Adults and children over 12 years: Weeks 1 and 2 50 mg/day. Weeks 3 and 4 100 mg/day in 2 divided doses. Maintenance: To achieve maintenance doses of 300-500 mg/day (in 2 divided doses), increase dose by 100 mg/day q 1-2 weeks. Children, 2-12 years: Weeks 1 and 2 0.6 mg/kg/day in 2 divided doses, rounded down to the nearest 5 mg. Weeks 3 and 4 1.2 mg/kg/day in 2 divided doses, rounded down to the nearest 5 mg. Maintenance: 5-10 mg/kg/day, to a maximum of 400 mg/day in 2 divided doses. To reach maintenance doses, increase the dose as follows q 1-2 weeks: Calculate 1.2 mg/kg/day and round down to the nearest 5 mg; add this amount to the previously administered daily dose.

Conversion from a single enzyme-inducing antiepileptic drug to lamotrigine alone.

Clients 16 years and older: 500 mg/day (maintenance dose) in 2 divided doses. To convert, titrate lamotrigine to 500 mg/day in 2 divided doses while maintaining the dose of the enzyme-inducing drug at a fixed level. Wtihdraw the enzyme-inducing drug by 20% decrements each q week over a 4-week period.
Back to Top
New Storeis
Most Read